Alembic Pharmaceuticals allots 80.47 lakh equity shares under QIP issue

Image
Capital Market
Last Updated : Aug 07 2020 | 12:32 PM IST
The fund raising committee of Alembic Pharmaceuticals at its meeting held on 07 August 2020 has approved the allotment of 80,47,210 Equity Shares of face value Rs. 2 each to eligible qualified institutional buyers at the issue price of Rs. 932 per Equity Share (including a premium of Rs. 930 per Equity Share) against the floor price of Rs. 980.75 per Equity Share, aggregating to approximately Rs. 750 crore, pursuant to the Issue.

Pursuant to the allotment of Equity Shares in the Issue, the paid-up share capital of the Company has increased to Rs. 39,31,26,248, comprising of 19,65,63,124 Equity Shares of Rs. 2 each.

The Issue opened on 3 August, 2020 and closed on 5 August, 2020.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 07 2020 | 12:12 PM IST

Next Story